About miBiome Therapeutics
miBiome Therapeutics is a company based in Mumbai (India) founded in 2019 by Ravi Shroff and Gautam Das. It operates as a B2B. miBiome Therapeutics offers products and services including DNA Reading, Scientific Consulting, and Computational Analytics. miBiome Therapeutics operates in a competitive market with competitors including Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
- Headquarter Mumbai, India
- Founders Ravi Shroff, Gautam Das
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mibiome Therapeutics Llp
- Date of Incorporation 16 May, 2019
- Jurisdiction Jogeshwart West Mumbai, Maharashtra, India
-
Annual Revenue
$45.73 K (USD)0as on Mar 31, 2021
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miBiome Therapeutics
miBiome Therapeutics offers a comprehensive portfolio of products and services, including DNA Reading, Scientific Consulting, and Computational Analytics.
Sequences DNA for understanding life, disease, and environment.
Provides expert guidance on genomic sequencing processes.
Utilizes software for in-depth biological data interpretation.
Funding Insights of miBiome Therapeutics
Investments & Acquisitions by miBiome Therapeutics
Financial Statements - miBiome Therapeutics
Mibiome Therapeutics Comparisons
Competitors of miBiome Therapeutics
miBiome Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
|
| domain | founded_year | HQ Location |
Genomic services are provided for the life sciences industry.
|
|
| domain | founded_year | HQ Location |
BGI is engaged in genomics and precision medicine solutions.
|
|
| domain | founded_year | HQ Location |
Automated genotyping services for murine cell lines are developed.
|
|
| domain | founded_year | HQ Location |
Clinical trial services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Molecular analysis services for research and drug development are offered.
|
Latest news on Mibiome Therapeutics
Frequently Asked Questions about miBiome Therapeutics
miBiome Therapeutics was founded in 2019.
miBiome Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Annual revenue of miBiome Therapeutics is $45.73K as on Mar 31, 2021.
miBiome Therapeutics specializes in genomic services, including DNA sequencing, scientific consulting, and computational analytics. They assist academics and commercial clients by delivering advanced technology for genetic research and applications. Based in Mumbai, India, the company focuses on improving accessibility and efficiency in genomics, processing samples and data to drive innovations in health and biotechnology.
miBiome Therapeutics offers DNA Reading, Scientific Consulting, and Computational Analytics.